	"Renal cell carcinoma, not otherwise specified" is not a sufficient diagnostic classification. Virchows Arch Yildirim NA, Bayrak BY, Cheng L, Akgul M. PMID: 42554860 [PubMed - as supplied by publisher]
	MRI Standards for Prostate Cancer Screening in the PRISM Consensus Recommendations. AJR Am J Roentgenol Ponsiglione A, Brembilla G. PMID: 42554687 [PubMed - as supplied by publisher]
	Biopsy Versus Clear-Cell Likelihood Score for Diagnosing Clear Cell Renal Cell Carcinoma in Small Renal Masses on MRI: A Propensity Score-Matched Analysis. AJR Am J Roentgenol Joo Y, Yoon J, Tse JR, Cho SW, Jung DC, Kang BC, Oh YT, Park JH. PMID: 42554684 [PubMed - as supplied by publisher]
	A Platform-Independent Binary Gene-Pair Signature Derived from CRPC-Enriched Single-Cell Transcriptomics for Predicting Recurrence-Free Survival in Prostate Cancer. Cancer Manag Res He Y, Li B, Tan Z, Jiang K, Ju W, Yu W, Zhang M, Liang C. PMID: 42553741 [PubMed]
	Case Report: Diagnosis and treatment report and literature review of 2 cases of VHL-deficient renal cell carcinoma. Front Oncol Wang Y, Gao T, Ren N, Liu Y, Li Q, Guo X. PMID: 42553075 [PubMed]
	Diet and Physical Activity as Mediators of Weight Loss in a Digital Prostate Cancer Survivorship Intervention for Men: Secondary Analysis of the PC-PEP Randomized Trial. Am J Mens Health Power B, Smith NK, Ilie G, Rendon RA, Mason R, Kokorovic A, MacDonald C, Patil N, Bowes D, Bailly G, Wilke D, Langley E, Rutledge R. PMID: 42552876 [PubMed - indexed for MEDLINE]
	Frailty and Social Isolation of Elderly Prostate Cancer Patients: A Chain Mediating and Network Analysis of Illness Perception and Acceptance. Nurs Open Liu Y, Shen C, Huang Y, Jin Y, Zhang X, Wang H, Zhou J, Yao X, Li H, Chen W. PMID: 42552627 [PubMed - indexed for MEDLINE]
	Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era. Ann Surg Oncol Filzmayer M, Petix M, Quarta L, Orlandi F, Goyal JA, Carmignani L, Briganti A, Micali S, Shariat SF, Wenzel M, Heß-Busch Y, Humke C, Saad F, Chun FK, Karakiewicz PI. PMID: 42552493 [PubMed - as supplied by publisher]
	PSMA PET in Prostate Cancer: Clinical Value, Access Challenges, and Priorities for Implementation. Eur Urol Oncol Peyrottes A, Turpin L, Hernández LF, Rivas JG, Rouprêt M. PMID: 42552166 [PubMed - as supplied by publisher]
	Re: Emanuele Messina, Antonella Borrelli, Alessandro Sciarra, et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2025;89:246-57. Eur Urol Luca S, Ferrando L, Porpiglia F. PMID: 42552153 [PubMed - as supplied by publisher]
	Beyond the Trial: Can Audit and Feedback Produce Lasting Improvements in Transurethral Resection of Bladder Tumor Quality? Fr J Urol Mercier J, de la Taille A, Vordos D, Duquesne I. PMID: 42551555 [PubMed - as supplied by publisher]
	Mortality in Medicare-aged Men with Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-Based Study. Urology Kim IE Jr, Hartman R, Gandhi K, Nikita N, Banks J, Kelly WK, Keith SW, Kim IY, Lu-Yao G. PMID: 42551541 [PubMed - as supplied by publisher]
	Urinary incontinence after treatment for localized prostate cancer: A systematic review and meta-analysis. Actas Urol Esp (Engl Ed) Amaris Vanegas AP, Cabrera Díaz DC, Salgar Prada JD, Sánchez Moreno JV, Gómez Rodríguez DP. PMID: 42551523 [PubMed - as supplied by publisher]
	Imaging modalities in advanced prostate cancer: interim analysis of the Spanish cohort of the RING registry. Actas Urol Esp (Engl Ed) Chernysheva D, Gómez Gómez E, Burgos Revilla J, Fernández Conejo G, García Barreras S, Linares Espinós E, Gómez Villanueva A, Domínguez Esteban M, Mera Errasti A, Breda A, Fanti S, Bjartell A, Padhani AR, Sanguedolce F. PMID: 42551522 [PubMed - as supplied by publisher]
	Effectiveness and Safety of Hormonal Doublet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter Real-World Study. Actas Urol Esp (Engl Ed) Guedes Oliva P, Pérez-Fentes D, De Pablos-Rodríguez P, Bardella-Altarriba C, Díaz-Pedrouzo A, Abuin-García J, Vera-Ballesteros FJ, Abella-Serra A, Ribera-Díaz D, Martínez-Corral ME, Gómez-Ferrer Á, Picola-Brau N, Martínez-Breijo S, Costa-Planells M, López-Abad A, García-Puche M, Jiménez Marrero P, Martínez Corral R. PMID: 42551521 [PubMed - as supplied by publisher]
	Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations. Clin Adv Hematol Oncol Lee MS, Shi CT, Kim TH, Morales Martinez GA, Vasdev R, Waddle M, Takahashi N, Boorjian SA, Khanna A. PMID: 42550814 [PubMed - indexed for MEDLINE]
	Deep learning-based prostate cancer diagnosis on MRI with hip prostheses: artifact and sequence effects. Abdom Radiol (NY) Nakai H, Kurata Y, Takahashi H, Adamo D, Froemming A, LeGout J, Kawashima A, Cai J, Kido A, Kuanar S, Gloe J, Borisch E, Riederer S, Khanna A, Takahashi N. PMID: 42550188 [PubMed - as supplied by publisher]
	Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS, AREN03B2 study committee. PMID: 42549996 [PubMed - as supplied by publisher]
	Cardiovascular-Kidney-Metabolic Syndrome Severity and Risk of Pancreatic Cancer in a Large Prospective Cohort. Diabetes Metab Res Rev Choi M, Heo SJ, Kwon YJ, Kang CM. PMID: 42549759 [PubMed - indexed for MEDLINE]
	Clinical-imaging fusion model for risk assessment of clinically significant prostate cancer. Front Oncol Chen Y, Yu Z, Xu J, Kang X, Liang L, He J, Li Y, Hu Q, Feng B, Liu P. PMID: 42548646 [PubMed]

Articles 1 - 20 / 180513

Page 1 of 9026



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy